lutetium has been researched along with paclitaxel in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alvarez, RD; Austin, JM; Grizzle, WE; Khazaeli, MB; Kilgore, LC; Lin, CY; LoBuglio, AF; Macey, DJ; Meredith, RF; Partridge, EE; Schlom, J | 1 |
| Eberwein, DJ; Ingram, AC; Knick, VC; Murray, DM; Ryan, CH; Stimmel, JB; Thurmond, LM; Witherspoon, SM | 1 |
1 trial(s) available for lutetium and paclitaxel
| Article | Year |
|---|---|
Intraperitoneal radioimmunochemotherapy of ovarian cancer: a phase I study.
Topics: Adenocarcinoma; Adolescent; Adult; Antibodies, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Injections, Intraperitoneal; Interferon Type I; Lutetium; Maximum Tolerated Dose; Middle Aged; Ovarian Neoplasms; Paclitaxel; Radioimmunotherapy; Radioisotopes; Radionuclide Imaging; Recombinant Proteins; Treatment Outcome | 2001 |
1 other study(ies) available for lutetium and paclitaxel
| Article | Year |
|---|---|
Adenocarcinoma cells exposed in vitro to Navelbine or Taxol increase Ep-CAM expression through a novel mechanism.
Topics: Adenocarcinoma; Animals; Antigens, Neoplasm; Antineoplastic Agents, Phytogenic; Biomarkers, Tumor; Cell Adhesion Molecules; Cell Survival; Chromium; Colonic Neoplasms; Epithelial Cell Adhesion Molecule; Female; G2 Phase; Humans; In Vitro Techniques; Lutetium; Male; Mice; Mice, Nude; Mitosis; Paclitaxel; Prostatic Neoplasms; Tumor Cells, Cultured; Vinblastine; Vinorelbine | 2003 |